The most treatable disorder in psychiatry still scares away the people who need it most

After giving a speech on ADHD in California, a man named Dan approached John Ratey with a specific worry. His nine-year-old grandson, Steven, had just been diagnosed with ADHD. Steven was having outbursts at home, couldn't settle at the dinner table, and was already failing at school after being held back a year. Steven's doctor had recommended medication. His parents were resisting, afraid it might damage him somehow, or mark him as different for good.

Dan wanted to know what he should tell them.

Ratey didn't hand Dan a simple yes or no. Instead he laid out a way of thinking about it: do a real risk and benefit analysis, not a gut reaction. How is the condition actually affecting Steven's schoolwork, friendships, and sense of himself right now? Is he already forming an identity as a failure? Are there other realistic ways to reverse the academic slide, and quickly enough to matter?

This kind of clear-eyed weighing matters because the fear around ADHD medication runs far ahead of the evidence. The psychologist Russell Barkley has called ADHD, left untreated, worse for life expectancy than most of the top killers in the country combined, and also called it, once treated, one of the most treatable conditions in all of psychiatry, with larger effect sizes and higher response rates than almost anything else psychiatrists prescribe. A 2018 review by researcher Samuele Cortese, pulling together 133 randomized studies, found medication effective for ADHD roughly seventy to eighty percent of the time, not perfect, but far from the coin flip many people assume.

Edward Hallowell and John Ratey are careful to say medication is a tool, not the whole answer, and that it works best alongside structure, exercise, sleep, and connection, and, crucially, when the person taking it actually wants to. Wanting it matters clinically, not just emotionally, because the placebo effect is real and measurable, and it strengthens the benefit of almost any treatment, including this one.

For Dan's grandson, and for anyone facing this decision, the actual question isn't whether medication is good or bad in the abstract. It's a specific, answerable question: given the real cost of doing nothing, what does the evidence say this particular tool can offer?

Before you decide anything, read what real clinicians and researchers actually say about ADHD medication, rather than leaning on internet rumor or half-remembered stigma. Take stock of what's already in place, the structure, sleep, exercise, and connection you or your child already rely on, since medication is meant to sit alongside those, not replace them. Get specific about the real cost of waiting, exactly how grades, friendships, or self-esteem have shifted, so the decision rests on evidence rather than vague dread. And hold off starting anything until there's genuine willingness on the part of the person taking it, because wanting to take a treatment measurably changes how well it works, which means patience here isn't delay, it's part of making the medicine actually effective.